Streetbeat News

Price Targets

SNDX

Guggenheim analyst Michael Schmidt maintains a Buy rating on Syndax Pharmaceuticals (NASDAQ:SNDX) and raises the price target from $40 to $42.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 12:48 pm

NXGN

Guggenheim analyst Jack Wallace has reiterated a 'Buy' rating on NextGen Healthcare (NASDAQ:NXGN) and maintained a price target of $22.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 12:47 pm

USM

Morgan Stanley analyst Simon Flannery has maintained an Equal-Weight rating on United States Cellular (NYSE:USM) and raised the price target from $26 to $27.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 25, 2023 | 12:47 pm

TROW

Morgan Stanley analyst Michael Cyprys has reiterated an Equal-Weight rating on T. Rowe Price Gr (NASDAQ:TROW) and maintained a $108 price target.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:46 pm

MEDP

Guggenheim analyst Sandy Draper maintains a 'Buy' rating on Medpace Holdings (NASDAQ:MEDP) and raises the price target from $252 to $273.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 12:45 pm

PG

Morgan Stanley analyst Dara Mohsenian has reiterated an Overweight rating on Procter & Gamble (NYSE:PG) and maintained a price target of $174.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:45 pm

NTR

Morgan Stanley analyst Vincent Sinisi has reiterated an Equal-Weight rating on Nutrien (NYSE:NTR) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:43 pm

SNDX

B. Riley Securities analyst Kalpit Patel has maintained a 'Buy' rating on Syndax Pharmaceuticals (NASDAQ:SNDX) and raised the price target from $34 to $36.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 12:43 pm

MOD

B. Riley Securities analyst Jeff Van Sinderen has maintained a 'Buy' rating on Modine Manufacturing (NYSE:MOD) and raised the price target from $40 to $45.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 12:42 pm

NFE

Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on New Fortress Energy (NASDAQ:NFE) but lowered the price target from $50 to $48.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:41 pm